Test Technology

LumiraDx Tests are produced on our bespoke, high-throughput manufacturing line to deliver precise microfluidic test strips.

Accurate and flexible

  • Use small clinical samples, including capillary blood
  • Can be used to measure a number of parameters
  • Quantitative or qualitative results are compared to standard laboratory reference methods
  • On Board Hematocrit determination integrated into some tests
  • Room temperature storage
  • Liquid quality controls are available

LumiraDx SARS-CoV-2 Ag Test

The LumiraDx SARS-CoV-2 Ag Test is a rapid microfluidic immunoassay detecting SARS-CoV-2 antigen

The test uses a nasal swab sample to detect antigen nucleocapsid protein in under 12 minutes at point of care. In clinical studies, the LumiraDx SARS-CoV-2 antigen test demonstrated 97.6% positive agreement versus RT-PCR in patients tested within 12 days of the onset of symptoms.

LumiraDx INR Test

The LumiraDx INR Test is an enzyme kinetic assay based on Thrombin activity.

The coagulation cascade is activated by the test reagents and INR is calculated from the measured PT-time. Haematocrit is also measured on the strip to ensure patients are within the 25-55% range. The accuracy of the LumiraDx INR Test is comparable to the ACL Elite lab reference method.

Not available in the US

LumiraDx D-Dimer Test

The LumiraDx D-Dimer Test is a rapid microfluidic immunoassay for quantitative determination of D-Dimer

The only D-Dimer Test providing fast, accurate, quantitative results in just 6 minutes from a fingerstick blood sample.1 Supporting confident decisions at the point of care with the LumiraDx Platform.


1 Based on current information at the time of publishing

Compliance documents

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. Available in the USA under Emergency Use Authorization for SARS-COV-2 assay.